Skip to main content

Table 5 Comparing groups of patients with normal and elevated uric acid level regarding comorbidities and polysomnographic data (n = 100)

From: Correlation between serum uric acid and pulmonary arterial hypertension based on echo probability in patients with obstructive sleep apnea syndrome

 

Total (n = 100)

Uric acid

Test of sig

p

Normal (n = 26)

Abnormal (n = 74)

No

%

No

%

No

%

DM

 No

24

24.0

8

30.8

16

21.6

χ2 = 0.883

0.347

 Yes

76

76.0

18

69.2

58

78.4

HTN

 No

20

20.0

6

23.1

14

18.9

χ2 = 0.208

0.648

 Yes

80

80.0

20

76.9

60

81.1

DVT

 No

94

94.0

20

76.9

74

100.0

χ2 = 18.167*

FEp < 0.001*

 Yes

6

6.0

6

23.1

0

0.0

Apnea hypopnea index

 Min.–max

7.70–55.0

7.70–39.0

16.80–55.0

t = 4.399*

 < 0.001*

 Mean ± SD

31.93 ± 11.78

23.90 ± 9.79

34.75 ± 11.15

 Median (IQR)

32.0 (22.0–39.0)

26.60 (17.8–29.60)

35.0 (26.10–45.0)

ODI

 Min.–max

1.70–60.0

1.70–60.0

15.0–60.0

U = 788.0

0.171

 Mean ± SD

22.21 ± 13.89

19.48 ± 15.47

23.17 ± 13.27

 Median (IQR)

18.60 (16.10–20.80)

15.0 (8.20–27.0)

18.60 (16.50–19.80)

t90%

 Min.–max

0.0–38.0

0.0–38.0

0.10–38.0

U = 404.0*

 < 0.001*

 Mean ± SD

7.17 ± 8.90

4.55 ± 10.42

8.09 ± 8.19

 Median (IQR)

5.30 (0.90–9.80)

0.10 (0.0–1.30)

6.40 (2.90–9.80)

  1. IQR Interquartile range, SD Standard deviation, t Student t-test, U Mann–Whitney test, χ2 chi-square test, FE Fisher exact, p p-value for comparing between different categories
  2. *Statistically significant at p ≤ 0.05